About this trial
The goal of this pilot, patient blinded randomized trial is to develop a mechanistic understanding of gait following fixation of unstable intertrochanteric hip fractures and return to function and pain control. The guiding hypothesis that will be tested in a subsequent clinical trial is that the InterTAN when compared to standard lag-screw cephalomedullary nails will have decreased post operative pain, earlier return to symmetric weight bearing, and quicker return to pre-injury functioning levels.
Eligibility criteria
Qualifiers
Non-pathologic fractures
OTA/AO classification 31A2, 31A3 fractures
Ability to participate in 4-MET equivalent activities without ambulatory assistance prior to injury
Disqualifiers
Inability to consent
Inability to participate in follow-up activities
History of chronic pain / current opioid treatment
Pre-injury ambulatory status requiring assistance device
Trial design
Treatments tested in this trial
- Synthes TFNA
- Trigen InterTAN
Treatment groups
Sponsors and collaborators
Paul E. Matuszewski
Lead sponsor
University of Kentucky
Sponsor institution